G6PC1 and type 2 diabetes mellitus: The results (Figure 6A for db/db mice, Figure 6E for HFD/STZ-induced T2DM mice) indicated that FX5 treatment restrained the mRNA levels of G6Pase and PEPCK in T2DM mice.